A Clinical Study of Iparomlimab and Tuvonralimab Combined With SOX Following Heterogeneous Radiotherapy as First-line Treatment for Unresectable Locally Advanced or Metastatic HER2-negative Gastric or Gastroesophageal Junction Adenocarcinoma

Name: A Clinical Study of Iparomlimab and Tuvonralimab Combined With SOX Following Heterogeneous Radiotherapy as First-line Treatment for Unresectable Locally Advanced or Metastatic HER2-negative Gastric or Gastroesophageal Junction Adenocarcinoma
License: Public Domain

Huazhong University of Science and Technology

ClinicalTrials.gov · Datasets · License: Public Domain

Open Source ↗

gastric cancer (diagnosis), gastric cancer (gc), gastroesophageal junction adenocarcinoma

This document is indexed with metadata only — full text is not available in the archive for this record. Open the official source ↗

Record · ID 152407
Retrieved via Conceptio — every document is proof-bundled with source, license, and retrieval metadata.